Literature DB >> 26048082

Pleural neoplastic pathology.

Georgia Karpathiou1, Dimitrios Stefanou2, Marios E Froudarakis3.   

Abstract

BACKGROUND/
PURPOSE: Malignant pleural effusion is a frequent situation in pulmonary medicine. However, it is sometimes difficult to recognize the underlying etiology. The aim of this review is to provide the key characteristics of primary and metastatic pleural neoplasms.
METHODS: A review of the recent literature regarding pleural neoplasia is provided.
RESULTS: Malignant pleural mesothelioma (MPM) is the commonest primary pleural epithelial tumor showing remarkable histological heterogeneity often with prognostic significance. Various genetic alterations like changes in INK4 locus, NF2, BAP1 but also epigenetic changes are present in MPM. It should be distinguished from atypical mesothelial hyperplasia, mainly through morphological and clinical criteria, and from other rare primary and metastatic tumors, for which immunohistochemistry is rather important. Solitary fibrous tumor, the commonest primary pleural mesenchymal tumor is characterized by STAT6 overexpression. Other primary tumors, like adenomatoid tumor, well-differentiated papillary mesothelioma, synovial sarcoma, vascular tumors, various other sarcomas, thymic tumors and tumors of uncertain histogenesis are rarely encountered in the pleura. In contrast, metastatic disease is the commonest neoplasia of the pleura, and especially lung, breast and lymphoid malignancies.
CONCLUSION: The basic pathological, immunohistochemical and molecular characteristics of these entities are provided in the current review, along with their differential diagnosis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mesothelioma; Metastatic disease; Molecular biology; Pleura; Pleural effusion; Solitary fibrous tumor

Mesh:

Substances:

Year:  2015        PMID: 26048082     DOI: 10.1016/j.rmed.2015.05.014

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

1.  Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies.

Authors:  Cyril Habougit; Béatrice Trombert-Paviot; Georgia Karpathiou; François Casteillo; Sophie Bayle-Bleuez; Pierre Fournel; Jean-Michel Vergnon; Olivier Tiffet; Michel Péoc'h; Fabien Forest
Journal:  Virchows Arch       Date:  2017-03-27       Impact factor: 4.064

Review 2.  Role of Immunohistochemistry in the Diagnosis of Solitary Fibrous Tumor, a Review.

Authors:  Bita Geramizadeh; Mahsa Marzban; Andrew Churg
Journal:  Iran J Pathol       Date:  2016

3.  ALK gene expression status in pleural effusion predicts tumor responsiveness to crizotinib in Chinese patients with lung adenocarcinoma.

Authors:  Zheng Wang; Xiaonan Wu; Xiaohong Han; Gang Cheng; Xinlin Mu; Yuhui Zhang; Di Cui; Chang Liu; Dongge Liu; Yuankai Shi
Journal:  Chin J Cancer Res       Date:  2016-12       Impact factor: 5.087

4.  Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.

Authors:  Frances E Lennon; Gianguido C Cianci; Rajani Kanteti; Jacob J Riehm; Qudsia Arif; Valeriy A Poroyko; Eitan Lupovitch; Wickii Vigneswaran; Aliya Husain; Phetcharat Chen; James K Liao; Martin Sattler; Hedy L Kindler; Ravi Salgia
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

5.  Performance of the UroVysion® FISH assay for the diagnosis of malignant effusions using two cutoff strategies.

Authors:  Débora C B Rosolen; Daniel K Faria; Caroline S Faria; Leila Antonangelo
Journal:  Cancer Med       Date:  2018-03-25       Impact factor: 4.452

6.  Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy.

Authors:  Georgia Karpathiou; Stavros Anevlavis; Olivier Tiffet; Francois Casteillo; Mousa Mobarki; Valentine Mismetti; Paschalis Ntolios; Andreas Koulelidis; Tiffany Trouillon; Nicolas Zadel; Sirine Hathroubi; Michel Peoc'h; Marios E Froudarakis
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

7.  The necessity of a more aggressive initial surgical treatment in patients with mesothelioma of the testicular tunica vaginalis.

Authors:  Clement Brun; Sophie Giusiano; Khady Thiam; Julien Guinde; Marios Froudarakis; Philippe Astoul
Journal:  Ann Med Surg (Lond)       Date:  2019-10-12

8.  Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.

Authors:  Annalisa Bosi; Silvia Zanellato; Barbara Bassani; Adriana Albini; Alessandra Musco; Maria Cattoni; Matteo Desio; Elisa Nardecchia; Davide Giuseppe D'Urso; Andrea Imperatori; Lorenzo Dominioni; Douglas M Noonan; Lorenzo Mortara; Antonino Bruno
Journal:  J Immunol Res       Date:  2018-03-29       Impact factor: 4.818

9.  Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial.

Authors:  Maribel Botana-Rial; Lorena Vázquez-Iglesias; Pedro Casado-Rey; María Páez de la Cadena; María Amalia Andrade-Olivié; José Abal-Arca; Laura García-Nimo; Lucía Ferreiro-Fernández; Luis Valdés-Cuadrado; María Esther San-José; Francisco Javier Rodríguez-Berrocal; Alberto Fernández-Villar
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379

Review 10.  Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology.

Authors:  Georgia Karpathiou; Michel Péoc'h; Anand Sundaralingam; Najib Rahman; Marios E Froudarakis
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.